These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1968153)

  • 1. Genotoxicity studies of gastric acid inhibiting drugs.
    Burlinson B; Morriss SH; Gatehouse DG; Tweats DJ
    Lancet; 1990 Feb; 335(8686):419-20. PubMed ID: 1968153
    [No Abstract]   [Full Text] [Related]  

  • 2. Intragastric acidity and serum gastrin after sufotidine.
    Mela GS; Caputo E; Villa G; Savarino V; Zentilin P
    Gut; 1990 Sep; 31(9):1087-8. PubMed ID: 1976577
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.
    Katz LB; Tobia AJ; Shriver DA
    J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential hazards of long-term acid suppression.
    Selway SA
    Scand J Gastroenterol Suppl; 1990; 178():85-92. PubMed ID: 1980549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of acid and gastric carcinoids.
    Elder JB
    Gut; 1985 Dec; 26(12):1279-83. PubMed ID: 2867953
    [No Abstract]   [Full Text] [Related]  

  • 6. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
    Reeves JJ; Stables R
    Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of secretagogue selection on potency determinations for gastric acid antisecretory agents.
    Palumbo GJ; Nielsen ST
    Methods Find Exp Clin Pharmacol; 1988 Mar; 10(3):151-5. PubMed ID: 2898575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentagastrin gastroprotection against acid is related to H2 receptor activation but not acid secretion.
    Tanaka S; Akiba Y; Kaunitz JD
    Gut; 1998 Sep; 43(3):334-41. PubMed ID: 9863477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of acid inhibitors on gastric mucus.
    Guslandi M
    Aliment Pharmacol Ther; 1996 Aug; 10(4):669-70. PubMed ID: 8853775
    [No Abstract]   [Full Text] [Related]  

  • 10. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pharmacologically altered gastric pH on cadmium absorption from the diet and its accumulation in murine tissues.
    Waisberg M; Black WD; Chan DY; Hale BA
    Food Chem Toxicol; 2005 May; 43(5):775-82. PubMed ID: 15778018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic administration of H2-antagonists does not alter gastric secretory responses to histamine, or the antisecretory activity of sufotidine.
    Stables R; Humphray JM; Reeves JJ
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():7-13. PubMed ID: 1983348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological control of gastric acid secretion.
    Jack D
    S Afr Med J; 1988 Jul; 74 Suppl():8-10. PubMed ID: 2898813
    [No Abstract]   [Full Text] [Related]  

  • 14. [Movement of gastric acid secretion and influence of proton pump inhibitors on histamine H2 receptor antagonist resistant ulcer].
    Asaki S; Kimpara T; Ohara S; Hongo M
    Nihon Rinsho; 1992 Jan; 50(1):111-5. PubMed ID: 1347323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omeprazole and genotoxicity.
    Lancet; 1990 Feb; 335(8686):386. PubMed ID: 1968122
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of gastric acid suppressants on human gastric motility.
    Parkman HP; Urbain JL; Knight LC; Brown KL; Trate DM; Miller MA; Maurer AH; Fisher RS
    Gut; 1998 Feb; 42(2):243-50. PubMed ID: 9536950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H2-receptor antagonist nonresponders and omeprazole.
    Walker S; Treiber G; Sarem-Aslani A; Klotz U
    Dig Dis Sci; 1992 Aug; 37(8):1302. PubMed ID: 1354154
    [No Abstract]   [Full Text] [Related]  

  • 18. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
    Shamburek RD; Schubert ML
    Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of H2-receptor antagonists upon physiological acid secretory states in animals.
    Pendleton RG; Cook PG; Shepherd-Rose A; Mangel AW
    J Pharmacol Exp Ther; 1985 Apr; 233(1):64-9. PubMed ID: 2858583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
    Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
    Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.